Effects of peripheral and central administration of calcium channel blockers in the naloxone-precipitated abstinence syndrome in morphine-dependent rats
- PMID: 3609136
- DOI: 10.1016/0014-2999(87)90176-2
Effects of peripheral and central administration of calcium channel blockers in the naloxone-precipitated abstinence syndrome in morphine-dependent rats
Abstract
The effects of two calcium channel blockers (verapamil and flunarizine) were evaluated on the naloxone-precipitated syndrome in morphine-dependent rats. The withdrawal signs in saline-treated rats were mainly diarrhea, body weight loss, jumping and ptosis. On i.p. administration, verapamil and flunarizine prevented diarrhea and body weight loss but not jumping. Verapamil also reduced the incidence of ptosis at the highest dose tested (40 mg/kg). Administered i.c.v., 160 micrograms verapamil reduced the body weight loss and the number of jumps without modifying diarrhea or ptosis. The results show that calcium channel blockers inhibit morphine abstinence syndrome manifestations through both peripheral and central mechanisms.
Similar articles
-
Differential effects of L-type calcium channel blockers and stimulants on naloxone-precipitated withdrawal in mice acutely dependent on morphine.Psychopharmacology (Berl). 1991;104(3):397-403. doi: 10.1007/BF02246042. Psychopharmacology (Berl). 1991. PMID: 1718013
-
Blocking naloxone-precipitated withdrawal in rats and hamsters.Pharmacol Biochem Behav. 1992 Dec;43(4):1093-8. doi: 10.1016/0091-3057(92)90487-z. Pharmacol Biochem Behav. 1992. PMID: 1475293
-
Calcium channel inhibitors suppress the morphine-withdrawal syndrome in rats.Br J Pharmacol. 1986 Jul;88(3):561-7. doi: 10.1111/j.1476-5381.1986.tb10236.x. Br J Pharmacol. 1986. PMID: 3017487 Free PMC article.
-
Calcium antagonists: their role in neuroprotection.Int Rev Neurobiol. 1997;40:95-108. doi: 10.1016/s0074-7742(08)60717-5. Int Rev Neurobiol. 1997. PMID: 8989618 Review. No abstract available.
-
On the possible central effects of calcium antagonists.Acta Otolaryngol Suppl. 1988;460:80-6. doi: 10.3109/00016488809125139. Acta Otolaryngol Suppl. 1988. PMID: 2854941 Review.
Cited by
-
Differential effects of L-type calcium channel blockers and stimulants on naloxone-precipitated withdrawal in mice acutely dependent on morphine.Psychopharmacology (Berl). 1991;104(3):397-403. doi: 10.1007/BF02246042. Psychopharmacology (Berl). 1991. PMID: 1718013
-
Acute opioid dependence: characterizing the early adaptations underlying drug withdrawal.Psychopharmacology (Berl). 2005 Apr;178(4):353-66. doi: 10.1007/s00213-005-2155-0. Epub 2005 Feb 5. Psychopharmacology (Berl). 2005. PMID: 15696323 Review.
-
Involvement of the cyclic AMP system in the switch from tolerance into supersensitivity to the antinociceptive effect of the opioid sufentanil.Br J Pharmacol. 2000 May;130(1):174-80. doi: 10.1038/sj.bjp.0703304. Br J Pharmacol. 2000. PMID: 10781014 Free PMC article.
-
Concurrent nimodipine attenuates the withdrawal signs and the increase of cerebral dihydropyridine binding after chronic morphine treatment in rats.Naunyn Schmiedebergs Arch Pharmacol. 1993 May;347(5):483-6. doi: 10.1007/BF00166739. Naunyn Schmiedebergs Arch Pharmacol. 1993. PMID: 8321324
-
Gabapentin and D-cycloserine alone and in combination with naloxone in methadone-maintained humans responding under a naloxone novel-response discrimination procedure.Behav Pharmacol. 2025 Aug 1;36(5):265-275. doi: 10.1097/FBP.0000000000000823. Epub 2025 Apr 8. Behav Pharmacol. 2025. PMID: 40272204 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources